We found a matchYour institution may have access to this item. Find your institution then sign in to continue.Title4-Aminoethylamino-emodin--a novel potent inhibitor of GSK-3beta--acts as an insulin-sensitizer avoiding downstream effects of activated beta-catenin.AuthorsGebhardt R; Lerche KS; Götschel F; Günther R; Kolander J; Teich L; Zellmer S; Hofmann HJ; Eger K; Hecht A; Gaunitz FPublicationJournal of cellular and molecular medicine, 2010, Vol 14, Issue 6A, p1276ISSN1582-4934Publication typearticleDOI10.1111/j.1582-4934.2009.00701.x